Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current data on curarization].

P Duvaldestin1

  • 1Département Anesthésie Réanimation n. III, Hôpital Henri-Mondor, Créteil.

Therapie
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Competitive neuromuscular blocking agents work by blocking acetylcholine receptors at the neuromuscular junction. Significant receptor blockade (75-90%) is needed to reduce muscle strength, with presynaptic effects also contributing to fade phenomena.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of airway occlusion on breathing muscle electromyogram signals, during isoflurane anaesthesia, with and without the effects of fentanyl and hypercapnia.

British journal of anaesthesia·2011
Same author

[Sugammadex: a new approach to muscle relaxation and its reversal].

Annales francaises d'anesthesie et de reanimation·2009
Same author

Dose-response effect of serum butyrylcholinesterase activity after clinical doses of pancuronium.

European journal of clinical pharmacology·2008
Same author

[French survey of neuromuscular relaxant use in anaesthetic practice in adults].

Annales francaises d'anesthesie et de reanimation·2008
Same author

Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort.

British journal of anaesthesia·2007
Same author

[Thrombosis of a cardiopulmonary bypass circuit despite recommended hypocoagulation with danaparoid during the acute phase of type II heparin-induced thrombocytopenia].

Annales francaises d'anesthesie et de reanimation·2006
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Context:

  • Advances in understanding neuromuscular junction physiology at molecular and cellular levels.
  • Improved knowledge of neuromuscular blocking agent mechanisms.

Purpose:

  • To elucidate the mechanisms of action of neuromuscular blocking agents.
  • To explain the molecular basis of neuromuscular blockade and muscle weakness.

Summary:

  • Competitive neuromuscular relaxants primarily block the acetylcholine binding site on the acetylcholine receptor in its inactive state.
  • A substantial blockade (75-90%) of acetylcholine receptors is required to impair neuromuscular transmission and reduce muscle strength.
  • Presynaptic blockade of acetylcholine secretion during repetitive nerve stimulation contributes to phenomena like train-of-four fade.

Related Experiment Videos

Impact:

  • Enhanced understanding of neuromuscular pharmacology.
  • Potential for improved therapeutic strategies involving neuromuscular blockade.
  • Foundation for further research into neuromuscular junction function and dysfunction.